Close

Gilead Sciences (GILD) Beats as Expected - Morgan Stanley

October 29, 2021 7:26 AM EDT Send to a Friend
Morgan Stanley analyst Matthew Harrison reiterated an Overweight rating and $84.00 price target on Gilead Sciences (NASDAQ: GILD) after 3Q ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login